137 related articles for article (PubMed ID: 25144286)
1. Surgery for primary central nervous system lymphoma: is it time for reevaluation?
Bierman PJ
Oncology (Williston Park); 2014 Jul; 28(7):632-7. PubMed ID: 25144286
[TBL] [Abstract][Full Text] [Related]
2. Surgical Resection for Primary Central Nervous System Lymphoma: A Systematic Review.
Labak CM; Holdhoff M; Bettegowda C; Gallia GL; Lim M; Weingart JD; Mukherjee D
World Neurosurg; 2019 Jun; 126():e1436-e1448. PubMed ID: 30904794
[TBL] [Abstract][Full Text] [Related]
3. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
Thiel E; Korfel A; Martus P; Kanz L; Griesinger F; Rauch M; Röth A; Hertenstein B; von Toll T; Hundsberger T; Mergenthaler HG; Leithäuser M; Birnbaum T; Fischer L; Jahnke K; Herrlinger U; Plasswilm L; Nägele T; Pietsch T; Bamberg M; Weller M
Lancet Oncol; 2010 Nov; 11(11):1036-47. PubMed ID: 20970380
[TBL] [Abstract][Full Text] [Related]
4. The safety of resection for primary central nervous system lymphoma: a single institution retrospective analysis.
Cloney MB; Sonabend AM; Yun J; Yang J; Iwamoto F; Singh S; Bhagat G; Canoll P; Zanazzi G; Bruce JN; Sisti M; Sheth S; Connolly ES; McKhann G
J Neurooncol; 2017 Mar; 132(1):189-197. PubMed ID: 28116650
[TBL] [Abstract][Full Text] [Related]
5. The role of surgery in primary central nervous system lymphomas.
Villalonga JF; Alessandro L; Farez MF; Mormandi R; Cervio A; Alcorta SC; Muggeri A
Arq Neuropsiquiatr; 2018 Mar; 76(3):139-144. PubMed ID: 29809232
[TBL] [Abstract][Full Text] [Related]
6. Clinical Characteristics, Surgical Outcomes, and Prognostic Factors of Intracranial Primary Central Nervous System Lymphoma.
Ouyang T; Wang L; Zhang N; Zhang Z; Xiong Y; Li M; Hong T
World Neurosurg; 2020 Jul; 139():e508-e516. PubMed ID: 32311566
[TBL] [Abstract][Full Text] [Related]
7. Primary central nervous system lymphoma.
Mohile NA; Abrey LE
Neurol Clin; 2007 Nov; 25(4):1193-207, xi. PubMed ID: 17964031
[TBL] [Abstract][Full Text] [Related]
8. Low-grade primary central nervous system lymphoma in immunocompetent patients.
Jahnke K; Thiel E; Schilling A; Herrlinger U; Weller M; Coupland SE; Krümpelmann U; Stein H; Korfel A
Br J Haematol; 2005 Mar; 128(5):616-24. PubMed ID: 15725082
[TBL] [Abstract][Full Text] [Related]
9. Current management of primary central nervous system lymphoma.
Schultz CJ; Bovi J
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):666-78. PubMed ID: 20159361
[TBL] [Abstract][Full Text] [Related]
10. Trends in survival from primary central nervous system lymphoma, 1975-1999: a population-based analysis.
Panageas KS; Elkin EB; DeAngelis LM; Ben-Porat L; Abrey LE
Cancer; 2005 Dec; 104(11):2466-72. PubMed ID: 16240449
[TBL] [Abstract][Full Text] [Related]
11. Craniotomy and Survival for Primary Central Nervous System Lymphoma.
Rae AI; Mehta A; Cloney M; Kinslow CJ; Wang TJC; Bhagat G; Canoll PD; Zanazzi GJ; Sisti MB; Sheth SA; Connolly ES; McKhann GM; Bruce JN; Iwamoto FM; Sonabend AM
Neurosurgery; 2019 Apr; 84(4):935-944. PubMed ID: 29660011
[TBL] [Abstract][Full Text] [Related]
12. Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003 : time trends in a 15-year national survey.
Haldorsen IS; Krossnes BK; Aarseth JH; Scheie D; Johannesen TB; Mella O; Espeland A
Cancer; 2007 Oct; 110(8):1803-14. PubMed ID: 17721992
[TBL] [Abstract][Full Text] [Related]
13. Hemorrhagic Attitude in Frameless and Frame-Based Stereotactic Biopsy for Deep-Seated Primary Central Nervous System Lymphomas in Immunocompetent Patients: A Multicentric Analysis of the Last Twenty Years.
Callovini GM; Sherkat S; Sperduti I; Crispo F; Raus L; Gazzeri R; Telera S
World Neurosurg; 2021 May; 149():e1017-e1025. PubMed ID: 33476784
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance features of primary central nervous system lymphoma in the immunocompetent patient: a pictorial essay.
Yap KK; Sutherland T; Liew E; Tartaglia CJ; Pang M; Trost N
J Med Imaging Radiat Oncol; 2012 Apr; 56(2):179-86. PubMed ID: 22498191
[TBL] [Abstract][Full Text] [Related]
15. Results of combined-modality therapy for primary and secondary malignant lymphoma of the central nervous system (CNS).
Kawamura T; Koga S; Okamoto M; Kanno T; Iwamura H
Radiat Med; 2001; 19(3):145-9. PubMed ID: 11467381
[TBL] [Abstract][Full Text] [Related]
16. Primary central nervous system lymphoma in the elderly: the Cleveland clinic experience.
Xie H; Dahiya S; Murphy ES; Chao ST; Suh JH; Stevens GH; Peereboom DM; Ahluwalia MS
Anticancer Res; 2013 Aug; 33(8):3251-8. PubMed ID: 23898087
[TBL] [Abstract][Full Text] [Related]
17. Primary CNS lymphoma: the role of resection.
Shankar GM; Barker FG
Oncology (Williston Park); 2014 Jul; 28(7):637-8, 640, 642. PubMed ID: 25144287
[No Abstract] [Full Text] [Related]
18. The role of surgical resection in primary central nervous system lymphoma: a single-center retrospective analysis of 70 patients.
Wu S; Wang J; Liu W; Hu F; Zhao K; Jiang W; Lei T; Shu K
BMC Neurol; 2021 May; 21(1):190. PubMed ID: 33975554
[TBL] [Abstract][Full Text] [Related]
19. Primary central nervous system lymphoma.
Ferreri AJ; Reni M
Crit Rev Oncol Hematol; 2007 Sep; 63(3):257-68. PubMed ID: 17590348
[TBL] [Abstract][Full Text] [Related]
20. Role of surgical resection in primary CNS lymphoma: a resurrected discussion.
Holdhoff M
Oncology (Williston Park); 2014 Jul; 28(7):641-2. PubMed ID: 25144288
[No Abstract] [Full Text] [Related]
[Next] [New Search]
